mRNA technology
Sanofi unveils $20bn US investment to boost R&D and manufacturing presence
The company is the latest major drugmaker to announce a significant investment in the country
Biogen unveils plans for new global headquarters and R&D hub in US
The company is expecting to relocate its Cambridge-based employees to the new site in 2028
AstraZeneca announces $2.5bn investment in China to boost R&D capabilities
The funds will go towards a new global research and development centre in Beijing’s BioPark
Ipsen announces launch of new UK headquarters in London life sciences community
The Paddington site will serve as one of the company’s three global hubs
ABPI publishes manifesto for government to accelerate UK life sciences industry
The trade association has called on political parties to commit to three broad goals and requirements
UK’s Autumn Budget details measures to boost life sciences sector
The new budget will aim to advance research and manufacturing in the UK
ABPI report shows improvement in UK industry clinical trial performance
The data showed a 15% increase in annual recruitment to UK industry clinical trials
BioIndustry Association reveals how UK is set to become a global leader in mRNA
Several companies and organisations have supported the development of mRNA
mRNA technology for universal flu vaccine shows early promise in US study
The evolving nature of influenza viruses requires frequent reformulation of vaccines
Pfizer doses first patients with mRNA-based influenza vaccine
Available vaccine strains that match circulating influenza viruses offer only 40%-60% protection
Sanofi to buy acne specialist Origimm
The acquisition brings Origimm’s ORI-001 vaccine candidate against acne vulgaris into Sanofi’s vaccine pipeline, building its strength in mRNA technology
BioNTech to use mRNA technology to develop a ‘highly effective’ malaria vaccine
The company aims to develop a vaccine candidate and also boost mRNA manufacturing capabilities on the African continent